Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.

Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing life-transforming therapeutics for people living with genetically driven diseases, today ...

Neuropathy, skin rash, and hyperglycemia following enfortumab vedotin treatment were associated with improved PFS in ...

The public is invited to participate in an islandwide sign-waving event Friday to raise awareness about drug overdoses, ...

Vertigo Releasing has released a poster and trailer for Sew Torn, the neo-noir crime thriller from director Freddy MacDonald. The film follows Barbara (Eve Connolly), a seamstress who finds herself ...

Dennis Quaid and Annaleigh Ashford star as a serial killer and his estranged daughter in Happy Face. Check out the show’s ...

The billboards have been seen in Andersonstown as well as other areas of Belfast.

It’s been three months since California voters overwhelmingly approved Proposition 36, a new law that pledged to provide ...

Data on enfortumab vedotin plus pembrolizumab for advanced bladder cancer, along with updates on antibody-drug conjugates, ...

At stake is V-P Sara Duterte’s political survival, as she faces an impeachment trial after the midterm polls. Read more at ...

The abstract, Phase 1 Dose-Escalation Study of Next-Generation Nectin-4 Targeting Antibody-Drug Conjugate CRB-701 (SYS6002) ...

GC Biopharma, a South Korean biopharmaceutical company, announced on Feb. 10th that it presented development updates on its LSD (lysosomal storage disorder) pipelines at the WORLD Symposium 2025, held ...